Ranjan Prasad Devbhandari
Impact in
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research
-
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
Papers in
-
- Cell Adhesion Molecules Research 3
-
- Pharmacovigilance and Adverse Drug Reactions 1
- Journals
- PLoS ONE (2 papers)Hepatology (2 papers)Cancer (1 paper)Gastroenterology (1 paper)Kathmandu University Medical Journal (1 paper)
In The Last Decade
Ranjan Prasad Devbhandari
9 papers receiving 454 citations
Peers
Comparison fields: 5 of 57
- Immunology and Allergy 115
- Cancer Research 152
- Hepatology 47
- Cell Biology 86
- Hematology 44
Countries citing papers authored by Ranjan Prasad Devbhandari
This map shows the geographic impact of Ranjan Prasad Devbhandari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranjan Prasad Devbhandari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranjan Prasad Devbhandari more than expected).
Fields of papers citing papers by Ranjan Prasad Devbhandari
This network shows the impact of papers produced by Ranjan Prasad Devbhandari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranjan Prasad Devbhandari. The network helps show where Ranjan Prasad Devbhandari may publish in the future.
Co-authors
The 25 scholars most cited alongside Ranjan Prasad Devbhandari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Adverse events following Immunization with Sinopharm (Vero Cell) inactivated COVID-19 vaccine: Adverse events of Vero Cell vaccine | 2021 | 1 |
| 2 | 2021 | 22 | |
| 3 | 2021 | 2 | |
| 4 | 2021 | 0 | |
| 5 | 2012 | 35 | |
| 6 | 2012 | 71 | |
| 7 | 2011 | 34 | |
| 8 | 2011 | 147 | |
| 9 | 2010 | 39 | |
| 10 | 2010 | 106 |
About Ranjan Prasad Devbhandari
Ranjan Prasad Devbhandari is a scholar working on Immunology and Allergy, Toxicology, Health, Cancer Research and Oncology, having authored 10 papers that have together received 457 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (3 papers), Cell Adhesion Molecules Research (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Protease and Inhibitor Mechanisms (2 papers), Vaccine Coverage and Hesitancy (2 papers), Pharmacovigilance and Adverse Drug Reactions (1 paper), COVID-19 and Mental Health (1 paper) and RNA modifications and cancer (1 paper). The work is most often cited by research in Immunology and Allergy (115 citations), Cancer Research (152 citations), Hepatology (47 citations), Cell Biology (86 citations) and Hematology (44 citations). Ranjan Prasad Devbhandari has collaborated with scholars based in China, Nepal and Ethiopia. Frequent co-authors include Jia Fan, Guo‐Ming Shi, Ai‐Wu Ke, Zhen‐Bin Ding, Xiaoyong Huang, Jian Zhou, Ying‐Hong Shi, Zhi Dai, Yang Xu and Xin‐Rong Yang. Their work appears in journals such as PLoS ONE, Hepatology, Cancer, Gastroenterology and Kathmandu University Medical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.